Abstract
This research aims to quantify the impact of raising the cost effectiveness threshold for end of life drugs and find that the effect on other NHS services could be substantial.
Original language | English |
---|---|
Number of pages | 5 |
Journal | BMJ |
Volume | 346 |
Issue number | f1363 |
DOIs | |
Publication status | Published - Mar 2013 |
Keywords
- end of life treatments
- NICE
- National Institute for Health and Clinical Excellence
- population
- National Health Service
- quality adjusted life year